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Abstract
Background: Among the available patient-reported outcome measures (PROMs) there is an absence of a PROM
with a specific focus on the impact of the wide variety of visual impairments following stroke.
Our aim was to develop a patient reported quality of life outcome measure for stroke survivors with visual impairment.
Methods: Potential items were sourced from a combination of existing PROMs from a systematic review and qualitative
in-depth interviews, duplicates were removed and items shortlisted. The initial pilot instrument was created following a
ranking exercise of these potential items and consultation with stroke survivors. Version 1 was piloted with 37
stroke survivors at acute and chronic stages. Version 2 was piloted with 243 stroke survivors with visual impairment at
acute and chronic stages. This data was analysed using the Rasch measurement model. Simultaneously, items from
Version 2 underwent a Delphi process with stroke survivors and stroke clinicians, to assess the importance of each item.
Final consensus decisions on item removal were made using the combined analysis from the Rasch measurement
model and Delphi process in a nominal group meeting.
Results: Due to the wide range of rank given to the majority of categories/items, only two items were discarded. Version
1 comprised of 102 items with 5 response categories relating to amount of difficulty. The pilot of Version 1 allowed item
reduction based on analysis of floor/ceiling effects and not applicable responses. Version 2 comprised of 62 items. Within
the nominal group meeting, the expert panel created a set of rules which aided them with decision making in addition
to the Rasch and Delphi analysis data. This resulted in the removal of 43 items and the combination of seven items to
create three new items. The expert panel also recommended the rewording of three items.
Conclusion: The Brain Injury associated Visual Impairment Impact Questionnaire (BIVI-IQ-15), a 15-item instrument with 4
response categories has been developed for capturing vision-related quality of life of stroke survivors with any of the
predominant types of visual impairment, in the presence of other impairments and for both inpatients and outpatients.
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Background
The prevalence of visual impairment following stroke
has been reported as 72% [1]. Visual impairment as a
result of stroke takes different forms across four main
categories: visual field loss, ocular motility defects, re-
duced central vision and visual perception problems [2].
These impairments have the potential to affect an indi-
vidual’s ability to perform activities of daily living (ADLs)
for example self-care, mobility and socialising [3]. An
individual with visual impairment may have reduced
level of independence [4]. A combination of limitations
has the potential to impact on an individual’s mood and
motivation [5, 6].
A patient reported outcome measure (PROM) is “any
report of the status of a patient’s health condition that
comes directly from the patient, without interpretation
of the patient’s response by a clinician or anyone else”
[7]. How an individual feels and functions in relation to
either their general health or a specific condition can be
captured using PROMs. By allowing an individual to
self-report using PROMs provides the opportunity for
concepts to be captured, which with other methods is
not possible [8]. PROMs can be used for a wide variety
of purposes and can provide a vehicle for the patient’s
voice, to inform clinicians and/or researchers with their
views on the impact of their health status [9, 10].
Within clinical practice, stable non-recovered stroke-re-
lated visual impairment show no change on objective test-
ing [2]. However, it is common for the stroke survivor to
adapt to the visual impairment; the best way to capture this
adaptation is by repeated measures of quality of life [3].
The availability of an instrument for measuring impact on
quality of life for visual impairment following stroke would
allow adaptation to be tracked formally from visit to visit.
For example, a pilot randomised controlled trial of inter-
ventions for stroke-related visual field loss suggested
vision-related PROMs assessing quality of life would be an
appropriate primary outcome measure for this population
[11]. Had quality of life not been measured in this trial, it
would not have been highlighted that one of the treatments
has the potential to improve quality of life in stroke survi-
vors with homonymous hemianopia.
The need to develop a PROM specific to measuring
the impact of the wide variety of visual impairment
post-stroke was confirmed by the critic of the existing
instruments available for measuring vision-related quality
of life in a systematic review [12]. A further systematic
review investigating the impact of stroke-related visual
impairment found a wide variety of instruments being
used in research [13]. For the studies in this review, it was
not always possible to isolate the impact of the stroke-re-
lated visual impairment due to question wording. Other
existing instruments pose a considerable burden on the
person completing, due to the high number of items. This
highlights the need for an appropriate robust instrument
to measure vision-related quality of life for stroke survi-
vors with visual impairment.
Our aim was to develop a patient reported outcome
measure for stroke survivors with visual impairment to
measure vision-related quality of life.
Methods
Development process
The development process is outlined in Fig. 1. Ethical
permission was granted by the West of Scotland
Research Ethics Committee (14/WS/0090) and the
University of Liverpool REC (IPHS-14145-040).
Item generation
Items were sourced from a database created from the in-
struments found to be potentially relevant to stroke sur-
vivors with visual impairment in a systematic review of
existing PROMs [12]. The total item pool was con-
structed of 1270 items. These items were coded, result-
ing in 20 categories. Lists of items were created by
summarising the focus of the items within each category
with the removal of duplications. This resulted in the
following number of items in each category: walking
(n = 9), near vision (n = 7), distance vision (n = 5), read-
ing (n = 5), driving (n = 8), travelling (n = 4), television
(n = 5), peripheral vision (n = 4), self-care (n = 8), lighting
(n = 5), general vision (n = 6), well-being (n = 11), colour
(n = 3), ocular pain (n = 3), social function (n = 9), role
limitations (n = 8), dependency (n = 4), binocular vision
(n = 5), symptoms (n = 11) and general health (n = 1).
The list of items was cross-checked against key themes
and codes obtained from one-to-one interviews con-
ducted with stroke survivors capturing their experience
of their post-stroke visual impairment [14]. No add-
itional items were identified.
Ranking exercise
A ranking exercise was conducted to identify key items
versus items not considered important for a new instru-
ment. The stakeholders identified as being required in-
cluded stroke survivors with visual impairment and eye
specialists involved in stroke care (i.e. orthoptists). These
groups were recruited by convenience sampling using
voluntary sector (e.g. charities) advertisement and clin-
ical meetings, respectively. Participants were requested
to rank the categories and items in their perceived order
from most important to least important; items which
they felt were missing could be added. Clinicians com-
pleted the exercise on paper and stroke survivors com-
pleted a two-part web-based version.
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Version 1 development
In view of the results of the ranking exercise, the deci-
sion was made to include all 20 categories and a max-
imum of nine items per category. The limit in the
number of items per category was to reduce the larger
categories. This was not based on a standardised cut-off
point across all categories; the variability in the number
of items in each category prevented direct comparisons
and, therefore, a standardised cut-off point. This resulted
in the loss of one item from two categories; well-being
and symptoms. ‘Adaptation’ was removed from the
well-being category and ‘starbursts’ from the symptoms
category. Stroke survivors and clinicians were in agree-
ment with the low ranking of these items.
Following the removal of duplicates, items were short-
listed by the research team if found to be appropriate; 1)
Fig. 1 Flow chart of the instrument development process
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in terms of language (e.g."driving...during rush hour on
the freeway" whereas motorway would be the English
terminology), 2) not being too detailed on the specifics
of an activity (e.g. "meal preparation - chop, slice, cut,
peel, use knives safely") and 3) not being too specific on
the location of an activity (e.g. “moving about in class-
rooms”). The short-list included multiple items under
several an item headings used in the ranking exercise;
for example, ‘watching TV’ had six short listed items.
Version 1 was constructed of 102 items, outlined in
Table 1, selected from the shortlisted items by the
research team in consultation with stroke survivors. A
decision was also taken by this group as to how the
items in the new instrument should be worded. This de-
cision was based on recommendations from the analysis
of existing instruments [12, 13]. All items asked about
“difficulty due to eyes or eyesight” to support the pur-
pose of the instrument. The scale was standardised,
using a five-point rating scale measuring the level of dif-
ficulty [15]. The scale ranged from 1 ‘none at all’ to 5 ‘it
limits my activity’, with an additional ‘not applicable’ op-
tion. A box was also provided to allow explanation of
why an item was not applicable. The exception to this
was for the two overall items, ‘general health’ and ‘rate
eyesight’ - both items used the same wording and a vis-
ual analogue scale ranging from zero (worst possible) to
100 (best possible).
Version 1 pilot
Version 1 was prospectively piloted with 1) acute stroke
survivors recruited at three NHS hospitals during rou-
tine clinical appointments for visual problems and 2)
long-term stroke survivors recruited through voluntary
sector channels. Participants were included if over 18
years of age and had a clinical or radiological confirmed
stroke with related visual impairment, and excluded if
they were unable to give informed consent. Both partici-
pant groups were asked to complete version one of the
new instrument and a feedback form. The feedback form
consisted of six questions about the clarity of instruc-
tions, repetition of questions, the response scale aimed
to collect the views of the participants on completing
the questionnaire. The questionnaire and feedback form
were completed in paper format. If required by the par-
ticipant the questionnaire was delivered in interview for-
mat by the clinician.
Version 1 item reduction & version 2 development
Analysis on the data collected as part of the version 1 pilot
was conducted, focusing on the spread of responses, to
identify items with large floor and ceiling effects, not ap-
plicable responses and inter-item correlation. Only a high
inter-item correlation (> 0.8) would be highlighted to the
nominal group at this stage. Items with having high
Table 1 Items included in Version 1
i. General health 33. Poor light 67. Strangers
ii. General vision 34.Bright light 68. Social activites
1. Blurred vision 35. Dim to bright 69. Entertaining
2. Distortion 36. Bright to dim 70. Outdoor activities
3. Objects jumping 37. Haloes 71. New friends
4. Deterioration 38. Recognising
colours
72. Usual activities
5. Fluctuation 39. Clothes 73. Confidence
6. Tiredness 40. Dull colours 74. Accomplishing
7. Two eyes
different
41. Pain 75. Limiting how long
8. Double vision 42. Strained 76. Limiting opportunities
9. Judging distance 43. Headaches 77. Usual standard
10. Unusual
appearance
44. Dryness 78. Toilet
11. Recognising
people
45. Watering 79. Dressing
12. Reading signs 46. Steps 80. Eating
13. Reading bus
numbers
47. Tripping 81. Medication
14. Clock 48. Crossing road 82. Pouring drink
15. Recognising faces 49. Familiar areas 83. Preparing food
16. Writing 50. Unfamiliar areas 84. Looking after
appearance
17. Work/hobbies 51. Crowded areas 85. Household chores
18. Finding 52. Indoors 86. Shopping
19. Money 53. Outdoors 87. Bathing
20. Watch 54. Uneven 88. Sad
21. Telephone 55. Ever driven 89. Frustrated
22. Finding next line 56. Driving during
daytime
90. Vulnerable
23. Ordinary size 57. Driving at night 91. Anxious
24. Small print 58. Seeing cars in
next lane
92. Worry
25. Large print 59. Driving in difficult
conditions
93. Isolated
26. Watching TV 60. Oncoming
headlights
94. Less control
27. Reading text 61. Parking 95. Stressed
28. Cinema 62. Car passenger 96. Not coping
29. Computer 63. Alone 97. Self-conscious
30. Suddenly
appearing
64. Public transport 98. Burden
31. Missing patches 65. Meeting family/
friends
99. Help from others
32. Objects to side 66. Eye contact 100. Stay at home
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inter-item correlation is suggestive that the items are in
effect duplications [16].
Version 1 to version 2 amendments
The data collected in the pilot of version 1 was used in a
nominal group session to develop version 2. Each
section and item were discussed individually in terms of
response frequencies, inter-item correlations, item word-
ing and participant feedback. The process of the meeting
followed three steps:
1) idea sharing,
2) group discussion and clarification,
3) decision agreement.
Version 2 pilot
Version 2 was piloted with acute and long-term
stroke survivors recruited from 11 NHS hospitals and
voluntary sector organisations in the same manner as
for version 1. Participants were included if over 18
years of age and had a clinical or radiological con-
firmed stroke with related visual impairment, and ex-
cluded if they were unable to give informed consent.
Participants who had completed version 1 were not
approached to complete version 2. The questionnaire
was completed in paper format. If required by the
participant the questionnaire was administered in
interview format by the clinician.
Delphi process
Alongside the clinical pilot of version two, the 62 items
were also used to create a reactive three-round elec-
tronic Delphi survey. This asked clinicians and stroke
survivors to rank each item in terms of importance on a
9-point scale from 1 ‘not important’ to 9 ‘critical’ and
categorise the items by relevance to types of visual im-
pairment following stroke or not relevant. Analysis of
consensus, stability, and agreement was conducted. The
detailed methods of this component of the development
process are published elsewhere [17].
Rasch analysis
Rasch analysis aims to maximise homogeneity of the
trait being measured and redundancy reduction with as
little impact on the measurement information by re-
moval of items and/or amendment of scoring levels to
create the most valid and simple measure possible [18].
The Rasch measurement model was used to evaluate
the 62-item version 2. Analyses were performed using
RUMM 2030 software (RUMM Lab, Australia) [19]. The
unrestricted ‘partial credit’ Rasch polytomous model was
used [20]. Items were removed from the scale and the re-
sultant scale was reassessed for fit, differential item func-
tioning (DIF), dimensionality and local dependency. Item
removal was an iterative process which required repetition
of these stages until an adequate solution for the scale was
found.
The following person factors were included along
with individual item responses for DIF analyses: age
(< 65 or > 65 years), gender (male or female), visual
impairment diagnosis (reduced central vision, ocular
motility defect, visual field defect or visual perception
problem), number of visual impairments (isolated or
multiple), location (inpatient or outpatient) and time
since stroke (hyper-acute, acute, sub-acute or
long-term). This enabled analysis of the instrument to
establish if the items worked in the same way irrespect-
ive of these factors. It was deemed important that the
instrument be suitable and without bias for: those of
working age and retired, the variety post-stroke visual
impairment and stroke survivors at different stages
post-stroke.
A flow chart of the Rasch analysis process is outlined
in Fig. 2. All stages of analyses were conducted as part
of the initial process of testing the instrument prior to
any changes being made. The following criteria were
used in the analysis:
 Disordered thresholds indicate that the scoring
categories are not working properly (participants are
not responding as predicted) which could be a result
of too many category options or the semantics of
the category labels being confusing [21].
 The individual person fit was assessed to identify
any individual persons that are misfitting, which
could skew the analysis [22]. Individuals who
responded in the expected way would fall within a
commonly accepted fit residual range of − 2.5 to +
2.5 [23–25]. Misfitting persons were not removed
during this analysis.
 Individual item fit was assessed formally using three
statistics; fit residuals, chi-square probability and
F-statistic. Items which are working as expected
have commonly accepted fit residuals within the
range of − 2.5 to + 2.5, a non-significant (p > 0.05)
Chi-square and F-statistic [23, 24, 26].
 The presence of DIF relating to the person factors
included is indicated with a significant result (p < 0.05).
 Local independence is violated when responses to
items are interrelated to each other [27].
Dependency between items changes the probabilistic
structure and can cause an overestimation of
construct validity and reliability of the instrument
[24, 28]. Local dependence can be identified using
residual correlations of the items. A cut-off point of
0.2 above the average of all item residual correlations
was used to identify local dependence in these
analyses [24, 27].
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 Unidimensionality is a principle of measurement
in which only one attribute is measured at any
one time. Principal Component Analysis (PCA)
is conducted using fit residuals (the differences
between the expected and observed responses)
for each person and each item [29]. Person
estimates (ability) are generated from two subsets of
items (most negative loading residuals and most
positive loading residuals) and compared against each
other on an individual person basis using paired t-tests
[29, 30]. If > 5% of t-tests run are statistically significant
(< 0.05), multidimensionality is indicated [29].
Fig. 2 Methodological stages of Rasch Model analysis, all stages completed as part of the initial process prior to any changes being made.
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There are numerous reasons to consider the removal
of an item; poor item fit, DIF, local dependence and
multidimensionality. In view of the aim of the new
instrument to be appropriate for all stroke-related visual
impairment at all stages post-stroke, during this analysis
the method of dealing with DIF was item deletion.
Removing items changes the relationship between the
remaining items and the model. Therefore this process
was conducted in an iterative manner with the removal
of only one item at a time [30, 31]. Following the removal
of any item the analysis was rerun, as outlined in Fig. 2.
Final consensus process
To finalise the item removal decisions with input from
stroke survivors and clinicians, both the three-round
Delphi survey and Rasch analysis were presented at a
nominal group meeting. The session was organised into
ten tasks.
Each participant was given the data sets relevant for
tasks one to eight. The data sets included response his-
tograms from the final round of the Delphi survey, and
explanations relating to Rasch analysis findings.
The following steps were used for each task [32]:
1. Verbal and written presentation of the data set with
questions to consider.
2. Generation of ideas and opinions in silence.
3. Feedback from each participant in turn to the
group, listed by the facilitator on a flip-chart for
reference during the discussion.
4. Group discussion regarding the feedback.
5. Voting and decision agreement regarding inclusion
or exclusion of items.
The consensus definition used for the session when
voting was an acceptable resolution, one that can be
supported, even if not the ‘favourite’ of each individual.
Tasks one to three dealt with items which required ex-
clusion during Rasch analysis due to either individual
item misfit or differential item functioning (DIF). The
participants were asked to consider three questions for
each of the items within these first three sets:
a) Are these items important to measuring vision-
related quality of life?
b) If an item is important, is the topic covered by
another item?
c) Can this item be excluded?
Tasks four to eight dealt with items for which local
dependence had been detected. The participants were
given the items in groups which had been found to have
local dependence and asked to choose which item(s)
could be excluded.
Results
Ranking exercise
Fifty-nine orthoptists, one ophthalmologist and 61
stroke survivors participated in the ranking exercise.
The web-based version completed by stroke survivors
was divided into two parts which caused some difficul-
ties with completion. This resulted in 21 completions for
the whole ranking exercise. Fifty-nine responded to part
one of which, 18 were incomplete, and 25 responded to
part two, of which four were incomplete. All complete
and incomplete responses were used to maximise the
available information [33].
Both the category and individual item rankings dis-
played a wide range of ranks. Stroke survivors gave the
full range of rank for all items within a category, for nine
out of twenty categories. Clinicians used the full range
of rank for all items within a category for eight out of
twenty categories. Only in four of the twenty categories
did both stroke survivors and clinicians use the full
range of rank for less than half the items [33].
Version 1 pilot
Following 12months of recruitment (July 2014 to June
2015) 37 questionnaires were returned from 52 recruited
participants (71.2% return rate), from. A decision was
taken that the lack of recruitment was most likely due to
the high number of items (n = 102) within the instru-
ment. Due to the low number of returns, Rasch analysis
was not possible at this stage.
The participant feedback received regarding version 1
supported the need for item reduction. Of those who
completed version one of the pilot instrument, 15 partic-
ipants (40.5%) returned a feedback form. The majority
(73.3%, n = 11) reported that the instructions were clear.
There was an equally split view on whether the instru-
ment had repetitive items. The majority (66.7%, n = 8)
reported that no change was required to the scale. Of
those that reported the scale should be changed the
comments included for example, “a little bit and moder-
ate are hard to define”.
In view of both the low recruitment rate and partici-
pant feedback, a first round item reduction was required
to increase subsequent recruitment.
Version 1 item reduction & version 2 development
Floor-ceiling effects
Floor effects were apparent within the colour category (3
items) with the percentage response as option 1 ‘none at
all’ ranging from 62.2 to 75.7%. Within the self-care cat-
egory, eight of the ten items (excluding ‘household
chores’ and ‘shopping’) had floor effects ranging from
62.2 to 78.4%. The largest ceiling effect was found in the
‘ever driven’ item; 54.1% responded choosing the max-
imum score equivalent to ‘so much I can’t do this
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activity’. The only other option chosen for this item was
equivalent to ‘not applicable’. The remaining items used
the full range of responses.
Not applicable option
Twenty-four of the items had not applicable response
rates which would exceed an acceptable level of missing
data of < 10% [34].
Five items had a 13.5% not applicable response rate;
‘crossing the road’, ‘walking on uneven ground’, ‘social ac-
tivities’, ‘entertaining at home’ and ‘making new friends’.
A further six items had a 16.2% not applicable response
rate; ‘doing work and hobbies’, ‘telling time on a wrist-
watch’, ‘noticing haloes’, ‘walking outdoors’, ‘limiting op-
portunities’ and ‘working to usual standards’. All items
within the travelling category had high not applicable
ratings ranging from 24.3 to 29.7%. A further five items
had higher not applicable response rates; the highest
being item ‘ever driven’ with 43.2%, followed by ‘watch-
ing a film at the cinema’ with 37.8%, ‘using a computer’
with 27.0%, ‘outdoor activities’ with 24.3% and ‘reading
bus numbers’ with 18.9%.
In cases where an item was not applicable to the par-
ticipant, they were asked to state the reason the item
was not applicable. From both the acute and long-term
stroke survivors a total of nine codes emerged; do not
do this activity (n = 73), not tried this activity yet (n =
41), still an inpatient (n = 31), can do with help (n = 26),
do not experience this problem (n = 23), problem caused
by other difficulty (n = 18), not working/retired (n = 11),
adaptation (n = 8) and did not understand the question
(n = 8).
Version 1 to version 2 amendments
One stroke survivor, one orthoptist and two statisticians
attended the nominal group session plus the facilitator.
A total of 29 items were combined to form 10 new
broader items, 16 items were reworded, and 21 items
were removed. A summary of the changes agreed are
outlined in Table 2.
The outcome of the nominal group meeting was the
production of version 2; constructed of 62 items.
To improve the usability of the PROM, the formatting
of version 2 was altered following comment in the ver-
sion 1 feedback form and the stroke survivor delegate at
the nominal group meeting. Alterations reduced the
repetition of “due to your eyes and eyesight” to once per
page rather than for every question.
Version 2 pilot
A total of 275 participants were recruited over a
17-month period; 236 participants from NHS hospitals
and 39 participants through the voluntary sector. A total
of 247 questionnaires were returned (89.8% return rate).
Of the 247 stroke survivors recruited who returned a
completed questionnaire 59.9% (n = 148) were male and
the mean age at time of recruitment was 68.8 years (SD
13.0). The median number of days since stroke onset at
time of recruitment was 45 days (IQR 10–207) and the
mean 493.0 days (SD 1474.7); the discrepancy due to a
number of individuals recruited from outpatient clinics
several months or years post-stroke. The mean Barthel
Index score as an indication of stroke severity for those
recruited by NHS hospitals was 14.4 (SD 5.9), indicating
a moderate dependency on average [35, 36]; 47.9%
(n = 101) were inpatients when recruited and 52.1%
(n = 110) were outpatients. Sixty-eight percent (n =
143) of the stroke survivors recruited by NHS hospi-
tals who returned a questionnaire had two or more
visual impairments. The types of visual impairment of
those that returned a questionnaire are outlined in
Table 3. The most commonly reported symptom was
visual field loss (52.6%, n = 111), followed by reading
difficulties (31.8%, n = 67).
Delphi process
One hundred and thirteen participants registered for the
Delphi survey; 47 (41.6%) completed all three rounds.
Consensus was reached on importance of 56.5% of items
in the three-round process; all as ‘critical’ (options 7–9)
- an indication for inclusion in the instrument. A con-
sensus was reached for 83.8% in the categorisation of
items. The majority (82.6%) of consensus were for rele-
vant to ‘all visual impairment following stroke’. However,
two items were deemed ‘not relevant’ and therefore po-
tentially suitable for removal. The detailed results of this
component of the development process are published
elsewhere [17].
The lack of item reduction achieved by the Delphi
process alone highlighted the need for additional methods
of item reduction.
Rasch analysis
The initial model fit for the scale was poor (χ2 = 2110.3,
p < 0.0001). The initial analysis demonstrated 46 misfit-
ting items, 156 instances of local dependency, 17 items
with DIF and 61 items with disordered thresholds. Prior
to any further analysis, the thresholds were reordered.
Reordering was achieved by combining response cat-
egories together, using the category probability curves,
category response frequencies and the nomenclature of
the categories as guides to which categories should be
combined whilst maintaining as many thresholds as
possible [37].
No items retained the original threshold order. The
two items with visual analogue scales were reduced from
101 options to 11 (ten thresholds), as the majority of
participants (89.9%) had selected a round number. Of
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the 60 items which originally had a 5-point rating scale
(four thresholds), ten items reduced the number of
thresholds to three, 47 items reduced to two and three
items reduced to dichotomous (one threshold).
Following threshold ordering the model fit improved
but remained poor (χ2 = 753.10, p < 0.0001), now
demonstrating 11 misfitting items, 102 instances of local
dependency, 12 items with DIF and 36.0% significant
paired t-tests indicating multidimensionality. Item fit
analysis showed eight had fit residuals either greater
than 2.5 or less than − 2.5, six had a significant Chi-
square result and ten had a significant F-statistic.
The order of item deletion is listed in Additional file 1,
along with the summary statistics of the analysis follow-
ing each item deletion. Item deletion began with the in-
dividual items identified as misfitting, with the order of
deletion was led by the degree of misfit. The order and
the reason for deletion is outlined in Additional file 2.
Following deletion of 43 items the summary statistics
improved to indicate the instrument had achieved fit
with the Rasch model (Additional file 1). The fit residual
means were close to zero and the standard deviation
close to one for item fit (mean − 0.193, SD 0.966) and
person fit (mean − 0.275, SD 1.235). The Chi-square
item-trait interaction statistic result was non-significant
with Bonferroni correction (p = 0.0332). Unidimensional
was indicated by 3.24% significant paired t-tests (< 0.05).
The person separation index of the current 19-item in-
strument was 0.84 (Cronbach’s alpha 0.90) exhibiting
good interval validity.
Targeting for the 19-item instrument is represented in
Fig. 3. The negative logit value of the person location
(mean − 1.545, SD 1.284) indicates the sample popula-
tion have experienced a higher vision-related quality of
life than the average of the scale, presenting evidence of
a ceiling effect. Despite this apparent mistargeting, less
than 5% of the sample population had extreme scores.
The analysis revealed a mistargeting of the instrument,
suggesting insufficient items to differentiate between
participants with a better vision-related quality of life.
This could be the result of participants with asymptom-
atic mild visual impairment (e.g. partial superior hom-
onymous quadrantanopia) or a visual impairment for
which the symptoms had been eliminated by treatment
(e.g. diplopia joined with a prism).
During the process of Rasch analysis the psychomet-
rics led the majority of decisions on which items to re-
move and in which order. However, on occasion, clinical
judgements were made by the research team when de-
ciding which items to delete in cases of local depend-
ence, resulting in some item selection being subjective.
The reasons for these decisions are outlined in the clin-
ical column of Additional file 2. Rasch analysis selects
the items with the best statistics, but this does not ne-
cessarily translate to the best items to clinically measure
vision-related quality of life of stroke survivors [38].
Final consensus process
Fourteen of the 47 participants who completed the third
round of the Delphi survey expressed an interest in par-
ticipating in the nominal group meeting (two stroke sur-
vivors, six orthoptists and six occupational therapists
(OT)). Five participants were able to attend the meeting
(two stroke survivors, two orthoptists and one OT) to
form the expert panel plus the facilitator. The group
followed the ten tasks outlined in Table 4.
The group unanimously agreed to remove seven of the
ten misfitting items. The reasons given for removal in-
cluded the Delphi results suggesting items were not rele-
vant to stroke-related visual impairment, items not being
vision-specific, lack of clarity of the question and cov-
ered better elsewhere in the instrument. A decision
could not be agreed on the remaining three (‘making eye
contact’, ‘participating in indoor social activities’ and ‘loss
of confidence’), therefore these were held for discussion
in task nine. Thirteen of the 14 items identified with DIF
had unanimous agreement for removal to allow com-
parison between inpatient and outpatient responses and
across different types of visual impairment. The excep-
tion was ‘using a computer’; it was viewed as an import-
ant item to future proof the instrument. The removal of
a further 16 items was agreed due to local dependency.
The reasons given for removal included the level of im-
portance from Delphi results, function based items were
clearer than symptom based items, potential crossover
with other stroke sequelae and the item not being
vision-specific, duplication, covered better elsewhere in
the instrument and ensuring all questions relevant for
both inpatients and outpatients.
In task nine during the discussion of all remaining
items, an additional five items were excluded: ‘objects
jumping around’, ‘unusual appearance’, ‘travelling as a
passenger’, ‘making eye contact’, ‘bathing and showering’.
Seven items were combined to form three items: 1) ‘par-
ticipating in indoor social activities’ and ‘participating in
outdoor social activities’ created ‘socialising’, 2) ‘accom-
plishing as much as would like’ and ‘usual standard’
Table 3 Types of visual impairment in acute stroke survivors
returning a questionnaire
Visual impairment n (%)
Visual field loss 182 (86.3)
Ocular motility defect 104 (49.3)
Central vision loss 77 (36.5)
Ocular alignment defect 44 (20.9)
Visual inattention 26 (12.3)
Visual perception problems 5 (2.4)
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created ‘doing what you want to do’, and 3) ‘loss of confi-
dence’, ‘not coping’ and ‘feeling a burden’ created ‘doing
things for yourself ’.
The instrument with agreed removal decisions was
reanalysed again using the Rasch measurement model.
The wording of six items was altered during the nominal
group process. However, for the purpose of further ana-
lyses the origin of the new item was used. No items indi-
cated misfit and the instrument was unidimensional.
Furthermore, four items displayed two residual inci-
dences of local dependence: ‘eating’ and ‘looking after
appearance’, ‘close-up vision’ and ‘following a line of
print’. These two options were put to the expert group,
who agreed to remove ‘eating’ and ‘close-up vision’.
Local independence was achieved with the removal of
these two items.
Through the nominal group process, the expert panel
created a set of rules which aided them with decision
making. First, that the instrument should be applicable
to both inpatient and outpatient populations. Another
rule was to shape the instrument using items which were
important when measuring vision-related quality of life;
this included the exclusion of symptom-related items.
The group considered that difficulty with symptoms did
not necessarily correspond to an impact on quality of
life. The group favoured items which focused on specific
activities which individuals either need to perform, or do
for enjoyment.
The instrument was reduced to 15 items, which are
listed in Table 5. In addition to reducing the number of
items within the instrument, the expert panel also re-
fined the wording of five items. This was for a number
of reasons: 1) to clarify what the question was asking, as
was the case with the ‘trips and falls’ item, 2) to dispense
with the specifics of indoors and outdoors, as with the
socialising items, and 3) to enable a new item to be cre-
ated from the combination of two or more items, which
was the case in the creation of ‘doing things for
yourself ’.
Rasch analysis was used to assess which best suited
the model; a 3-point or a 4-point rating scale. For the
purpose of this analysis the origin of the new item was
used, as was done for the post-nominal group analysis.
The model fit and unidimensionality were stronger using
the 4-point rating scale (three thresholds) across all the
items. The research team therefore decided to reduce
the number of response options for all items from five
in version two to four in version three. The resulting rat-
ing scale scores each item from 0 ‘none’ to 3 ‘stops what
I can do’, with the no response scored as 0 (perceived as
no difficulty experienced). The maximum possible score
on the 15-item scale would be 45, indicating the highest
impact.
Discussion
The development of the new instrument employed con-
sultation with stroke survivors and clinicians throughout
the development process, including item identification,
item selection and scoring, in order to create an instru-
ment suitable for measuring the impact on quality of life
caused by the visual impairments associated with stroke.
This paper has reported the process of developing a
new measure to capture vision-related quality of life of
stroke survivors with visual impairment. Although this
instrument was developed with and for stroke survivors,
there is the potential to broaden the target population of
Fig. 3 Person-item threshold distribution of the 19-item instrument following item deletion achieving fit to the Rasch model and unidimensionality; a
graphical representation of targeting
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Table 4 Overview of tasks for the nominal group process
Task One – Misfitting items
‘Deterioration’ ‘Dealing with strangers’
‘Eyes seeing differently’ ‘Participating in indoor social activities’
‘Dry eyes’ ‘Loss of confidence’
‘Watery eyes’ ‘Limit of how long activities can be done for’
‘Making eye contact’ ‘Household chores’
Task Two – Items with DIF for location and time since stroke person factors
‘Overall health’ ‘Crossing the road’
‘Overall vision’ ‘Moving around in unfamiliar areas’
‘Using a computer’ ‘Bumps into or against objects or people in
‘Seeing in bright light’ crowded areas’
‘Moving around on uneven ground’ ‘Moving around outdoors’
‘Stay at home’
Task Three – Items with DIF for primary visual impairment person factor
‘Double vision’ ‘Missing patches of vision’
‘Objects suddenly appearing’ ‘Noticing objects off to the side’
Task Four – Items with local dependency in the general and distance vision categories
‘Blurred vision’ OR ‘Objects jumping around’ OR ‘Fluctuation’
‘Blurred vision’ OR ‘Seeing something far away’
‘Seeing far side of a room’ OR ‘Seeing something far away’ OR ‘Seeing faces’ (Delete 2)
Task Five – Items with local dependency in the near vision and reading categories
‘Following a line of print’ OR ‘Reading same print size’
‘Writing’ OR ‘Close-up vision’ OR ‘Following a line of print’
Task Six – Items with local dependency in the lighting, moving around and role limitation categories
‘Seeing in poor or dim lighting’ OR ‘Adjusting to differing lighting’ OR ‘Change in colour perception’ (Delete 2)
‘Accomplishing as much as you would like’ OR ‘Usual standard’
‘Moving around in familiar areas’ OR ‘Moving around indoors’
Task Seven – Items with local dependency in the independent living and moving around categories
‘Toileting’ OR ‘Getting dressed’ OR ‘Preparing something to eat’ OR ‘Bathing or showering’
‘Getting dressed’ OR ‘Preparing something to eat’ OR ‘Taking medication’
OR ‘Looking after your appearance’ OR ‘Pouring a drink’ OR ‘Shopping’ (Delete 3)
‘Eating’ OR ‘Pouring a drink’
Task Eight – Items with local dependency in the well-being category
‘Negative emotions’ OR ‘Vulnerable’ OR ‘Burden to others’
‘Not coping’ OR ‘Self-conscious’
Task Nine – Overview of remaining items
All remaining items - any further exclusions required?
‘Objects jumping around’ ‘Travelling as a passenger’
‘Tired eyes’ ‘Making eye contact’
‘Judging distances’ ‘Participating in indoor social activities’
‘Unusual appearance’ ‘Participating in outdoor social activities’
‘Seeing something far away’ ‘Loss of confidence’
‘Close-up vision’ ‘Usual standard’
‘Finding something’ ‘Getting dressed’
‘Using a computer’ ‘Looking after your appearance’
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the new instrument to include brain injury and other
neurological conditions. This is based upon the fact that
the visual sequelae of stroke is broad and can include
visual field loss, ocular motility defects, reduced central
vision and visual perception problems and stroke can
also result in numerous other sequelae occurring simul-
taneously, such as physical disability, communication
problems and cognitive impairments [39–43]. The visual
impairments associated with a stroke can also result
from other neurological aetiologies, such as traumatic
brain injury (TBI), space occupying lesions, vascular, in-
flammation, e.g. multiple sclerosis (MS), infection, e.g.
meningitis and degeneration, e.g. Parkinson’s disease.
These conditions can also be associated with other
global signs and symptoms affecting mobility, communi-
cation and cognition. The 15-item instrument was
therefore named the Brain Injury associated Visual
Impairment Impact Questionnaire (BIVI-IQ-15).
A systematic review of the impact of visual impairment
following stroke on quality of life identified sub-categories
which displayed reduced scores in existing PROMs [13].
This allows a comparison of BIVI-IQ-15 to existing
vision-specific instruments. The NEI VFQ-25 used by five
studies had six common subscales with reduced scores for
stroke survivors with visual field loss compared to healthy
individuals: general health, general vision, near activities,
vision-specific mental health, driving and peripheral vision
[44–48]. Of these six subscales, the BIVI-IQ included
items related to three. The sub-categories not included
(general health, driving and peripheral vision) had all been
included in either version one or two of the instrument,
and subsequently removed for a variety of reasons; i.e. not
relevant to the majority of the target population or not
relevant to measuring vision-related quality of life.
One study included in the review had a study popula-
tion with reduced visual acuity in addition to visual field
loss. As a consequence, the list of sub-categories with
reduced scores was extended: general vision, near vision,
distance vision, social functioning, vision-specific mental
health, role difficulties and dependency [44]. The
BIVI-IQ contains items covering all these sub-categories.
This demonstrates that version three has incorporated
items relevant to the sub-categories which potentially re-
veal the impact of visual impairment following stroke.
It must be highlighted that the examples of these studies
used as comparison were predominantly stroke survivors
with visual field loss rather than the broader spectrum of
post-stroke visual impairment. There were no studies
found in the review which investigated the impact of ocu-
lar motility defects using a vision-specific PROM. One
study has used the NEI VFQ-25 to assess vision-related
quality of life in a small sample with spinocerebellar ataxia
of which 63.2% of participants had at least one ocular
motor defect [49]. They found reduced scores when com-
pared to a normal reference population in the following
sub-categories: general vision, near vision, distance vision,
driving, peripheral vision, vision-specific role difficulties,
dependency, social functioning and mental health. These
subcategories are similar to those raised with co-existing
visual field loss and reduced central vision [44]. The
BIVI-IQ has items which would be grouped into seven of
these nine sub-categories. The two exceptions are driving
and peripheral vision; the reasons for these disparities are
explained above. This comparison has exhibited that the
Table 5 Items to be included in the final version of the new
instrument
How much difficulty do you have, due to your eyes or eyesight with?
1. Tired eyes
2. Judging distances
3. Seeing something far away
4. Finding something
5. Using a computer
6. Following a line of print
7. Adjusting to differing lighting
8. Fear of tripping and falling
9. Getting about
10. Socialising
11. Doing what you want to do
12. Getting dressed
13. Looking after your appearance
14. Feeling negative emotion
15. Doing things for yourself
Table 4 Overview of tasks for the nominal group process (Continued)
‘Following a line of print’ ‘Feeling negative emotions’
‘Adjusting to differing lighting’ ‘Not coping’
‘Tripping and falling’ ‘Feeling a burden’
‘Moving around indoors’
E-Nominal Group
‘Eating’ OR ‘Looking after appearance’
‘Close up vision’ OR ‘Following a line of print’
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BIVI-IQ has face validity, as it contains items in
sub-categories which have previously demonstrated an
impact of visual impairment associated with a neuro-
logical cause.
In terms of size and the number of items, the BIVI-IQ
is the smallest of the vision-related PROMs previously
used with stroke survivors. Using the quality assessment
modified from Pesudovs et al. and Hamzah et al., which
was completed on all relevant existing PROMs as part of
the systematic review of existing instruments [50, 51],
the BIVI-IQ scored 13 out of 14 as demonstrated in
Table 6. This is equivalent to the Activity Inventory (AI),
the Daily Tasks Dependent on Vision (DLTV) question-
naire and the Veterans Affairs Low Vision Visual Func-
tioning (VA LV VFQ) questionnaire [12]. In this
systematic review, both the AI and DLTV were found to
have a serious flaw in the question wording when using
the instrument with individuals having co-existing
non-ocular deficits, in that there was no reference to
vision or eyesight [52, 53]. The VA LV VFQ had a poten-
tial high task burden with up to 192 items.
Three alternative instruments which had not previously
been validated with stroke survivors were identified in this
review; the Impact of Vision Impairment (IVI), the
Vision-related Quality of Life (VQoL) questionnaire and
Visual Symptom and Quality of Life (VSQ) questionnaire
[54–56]. Both the IVI and VQoL measure frequency, i.e.
“In the past month, how much has your eyesight inter-
fered with …” [55, 56]. These questionnaires would not be
appropriate for use soon after onset of the condition. An
element of memory is also required to answer these items,
which may cause difficulties in the presence of cognitive
impairment. The VSQ does contain some items measuring
frequency but this is not standardised throughout the
whole instrument. During the development of the
BIVI-IQ these elements were avoided, with all questions
specifying “difficulty due to your eyes or eyesight” and the
rating scale measuring the amount of difficulty experi-
enced at the time of completion.
This study has been able to demonstrate the BIVI-IQ
fulfils some of the criteria considered to be important
when selecting a PROM [57, 58]. Unidimensionality has
been demonstrated using Rasch analysis indicating
internal consistency [57]. Face and content validity can
be argued due to the employment of stroke survivors
and clinicians at every stage of development [59]. This
involvement also aids with creating an acceptable instru-
ment. However, the BIVI-IQ-15 has not yet been
assessed in its current form and the Rasch analysis pre-
sented in this study does not reflect the final version; ap-
propriate psychometric validation of this should be
included in a future validation study. Other criteria are
yet to be satisfied and require testing in a further valid-
ation study; specifically precision, reproducibility, con-
struct validity and responsiveness [57].
The BIVI-IQ was developed to be suitable for any of
the four main categories of visual impairment. The
population sample completing the version two pilot had
a range of dependency as measured by the Barthel
Index, indicating it is suitable to measure vision-related
quality of life in the presence of other impairments. The
BIVI-IQ would be suitable for use in routine practice or
Table 6 Quality assessment of BIVI-IQ using the modified quality assessment tool for evaluation of PROMs from Hepworth et al.
(2015) [12]
Quality criteria Definition BIVI-IQ
Pre-study hypothesis The pre-study specification of the aim of the
instrument and the intended population
√√ A clear description is provided of the aim of the instrument and
the intended population
Intended population The extent to which the instrument has been
studied in the intended population
√√ Intended population studied
Actual content area The extent to which the content meets the
pre-study hypothesis specifications
√√ Content is intended and is relevant to the intended population
Item identification Selection of the items relevant to the target
population for inclusion in the pilot instrument
√√ Comprehensive consulting with patients (focus groups or
in-depth interviews) and a literature review
Item selection Determining the items included in the final
instrument
√√ A pilot instrument was developed and tested with Rasch or
factor analysis and statistical justification provided for removing
items, plus items with floor and ceiling effects removed and the
amount of missing data considered
Scoring A description of how the instrument should
be scored
√√ Rasch scoring of a statistically justified response scale
Views of stroke patients
considered
The percentage of stroke patients involved in
item identification during the development
of PROMs
√ Less than 50% of stroke patients were involved in the consultation
with patients in the item identification
Stroke population The extent to which the instrument has
been studied in a stroke population
√√ Stroke population studied
√√ positive rating; √ minimal acceptable rating; X negative rating
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research settings. It is short, only taking a few minutes
to fill out and easy to use for self-completion.
In cases of asymptomatic mild visual impairment (e.g.
partial superior homonymous quadrantanopia) or a vis-
ual impairment for which the symptoms had been elimi-
nated by treatment (e.g. diplopia joined with a prism),
the visual impairment may not have any impact on the in-
dividuals’ vision-related quality of life. Further in-depth
investigation is required for these groups to establish if an
asymptomatic visual impairment does or does not affect
individuals’ vision-related quality of life.
Conclusion
Prior to this body of work, there were no PROMs specif-
ically designed to measure the impact of visual impair-
ment following stroke on quality of life. In conclusion,
the BIVI-IQ questionnaire is presented; a 15-item instru-
ment reporting quality of life for individuals with visual im-
pairment related to stroke. An independent validation is
now required to confirm that the BIVI-IQ is an effective tool
across acquired brain injuries causing visual impairment. Fu-
ture work will involve maximising interpretability and ex-
ploration of the barriers and solutions to implementation.
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